Skip to main content

Table 2 Clinical characteristics and oncological status by area of residence

From: Clinical outcomes in patients with solid tumors living in rural and urban areas followed via telemedicine: experience in a highly complex latin american hospital

Characteristics

Urban Area

n = 704

Rural Area

n = 566

Total

n = 1270

Time since cancer diagnosis, months*

34.0

(16.0–60.0)

36.0

(18.0–60.0)

36.0

(17.0–60.0)

Cancer status

 

Local

504 (71.6%)

418 (73.9%)

922 (72.6%)

Metastatic

200 (28.4%)

148 (26.1%)

348 (27.4%)

Cancer therapy

 

Currently in treatment

436 (61.9%)

366 (64.7%)

802 (63.1%)

Recentlya

61 (8.7%)

47 (8.3%)

108 (8.5%)

Previouslyb

180 (25.6%)

140 (24.7%)

320 (25.2%)

Has not been treated

27 (3.8%)

13 (2.3%)

40 (3.1%)

Treatment intent c

 

Curative/Adjuvant

185 (42.4%)

131 (35.8%)

316 (39.4%)

Palliative

15 (3.4%)

25 (6.8%)

40 (5.0%)

Maintenance

236 (54.1%)

210 (57.3%)

446 (55.6%)

Functional status - ECOG scale

 

0 - Fully active, able to carry on all predisease performance without restriction

262 (69.3%)

230 (69.7%)

492 (69.0%)

1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work

73 (19.3%)

64 (19.1%)

137 (19.2%)

2 - Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about for more than 50% of waking hours

20 (5.3%)

19 (5.7%)

39 (5.5%)

3 - Capable of only limited selfcare; confined to a bed or chair for more than 50% of waking hours

18 (4.8%)

14 (4.2%)

32 (4.5%)

4 - Completely disabled; cannot perform any selfcare; totally confined to a bed or chair

5 (1.3%)

8 (2.4%)

13 (1.8%)

No data

505

52

557

  1. * Median (IQR)
  2. a Patients who completed treatment 6 months before the start of the study
  3. b Patients who completed treatment more than 6 months before the start of the study
  4. c Only patients with active treatment during the study period were considered
  5. ECOG: Eastern Cooperative Oncology Group